Lonza Group AG (OTCMKTS:LZAGY) Short Interest Up 77.8% in March

Lonza Group AG (OTCMKTS:LZAGY - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,800 shares, a growth of 77.8% from the March 15th total of 2,700 shares. Based on an average daily volume of 328,600 shares, the days-to-cover ratio is currently 0.0 days.

Lonza Group Price Performance

LZAGY stock traded down $1.28 during mid-day trading on Friday, hitting $58.26. 41,451 shares of the company were exchanged, compared to its average volume of 173,835. The business has a fifty day simple moving average of $54.77 and a 200-day simple moving average of $45.88. The company has a current ratio of 1.77, a quick ratio of 1.20 and a debt-to-equity ratio of 0.27. Lonza Group has a 12-month low of $34.19 and a 12-month high of $66.00.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft raised shares of Lonza Group from a "hold" rating to a "buy" rating in a report on Friday, February 2nd.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.